Dec 25, 2025 • MarketBeat
NEUTRAL
Harbor Capital Advisors Inc. Sells 304,051 Shares of RadNet, Inc. $RDNT
Harbor Capital Advisors Inc. has significantly reduced its stake in RadNet, Inc. (NASDAQ:RDNT) by selling 304,051 shares, representing a 71.0% decrease in its holdings. The fund now owns 124,390 shares of the medical research company's stock, valued at $9.48 million, making RadNet its 14th largest position. Despite this reduction, other institutional investors have recently increased their holdings in RadNet, and analysts maintain a "Moderate Buy" consensus rating for the stock.
Dec 23, 2025 • MarketBeat
SOMEWHAT-BULLISH
RadNet (NASDAQ:RDNT) Trading Down 3.5% - Time to Sell?
RadNet (NASDAQ:RDNT) shares fell 3.5% on Monday with significantly lower trading volume, closing at $73.99. Despite a consensus "Moderate Buy" rating and an average price target of $87.60 from analysts following several upgrades, some analysts and Weiss Ratings remain negative. The company reported mixed fundamentals, missing EPS estimates while seeing revenue growth, but has a negative net margin, and insiders have recently sold shares.
Dec 23, 2025 • MarketBeat
NEUTRAL
Squarepoint Ops LLC Sells 48,775 Shares of RadNet, Inc. $RDNT
Squarepoint Ops LLC significantly reduced its stake in RadNet, Inc. (NASDAQ:RDNT) by 77.2%, selling 48,775 shares, though other institutions like Norges Bank, Castleark Management LLC, and Emerald Advisers LLC increased their holdings. RadNet reported a Q2 earnings miss but beat revenue expectations with 13.4% year-over-year growth, and analysts maintain a "Moderate Buy" rating with an $87.60 price target. Insiders also sold approximately 50,000 shares in the last quarter, valued at over $3.9 million.
Dec 22, 2025 • Stock Traders Daily
NEUTRAL
(RDNT) as a Liquidity Pulse for Institutional Tactics
This article provides an in-depth analysis of Radnet Inc. (NASDAQ: RDNT), highlighting divergent sentiment across various time horizons and an exceptional 55.0:1 risk-reward setup. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The report also includes multi-timeframe signal analysis, identifying key support and resistance levels for near-term, mid-term, and long-term outlooks.
Dec 22, 2025 • Radiology Business
SOMEWHAT-BEARISH
Short-selling investment startup accuses RadNet of exaggerating its success
Hunterbrook, a short-selling investment firm, alleges that diagnostic imaging center operator RadNet Inc. has exaggerated its success by inflating same-center growth numbers. Hunterbrook claims RadNet's practice of closing and consolidating nearby centers artificially boosts these figures, leading to an overestimation of organic growth. However, investment firm Raymond James has refuted these claims, labeling RadNet's stock a "strong buy" and arguing that Hunterbrook's criticisms are based on publicly known and disclosed data points.
Dec 22, 2025 • Finviz
BEARISH
3 Reasons RDNT is Risky and 1 Stock to Buy Instead
This article evaluates RadNet Inc. (RDNT) and provides three reasons why investors should be cautious despite its recent stock performance. The author highlights limited distribution channels, a shrinking adjusted operating margin, and mediocre free cash flow margin as key concerns. The article concludes by suggesting alternative investment opportunities for readers.